ICD-10 Coding for Benzodiazepine Dependence(F13.10, F13.10U, F13.20)
Explore the ICD-10 coding for benzodiazepine dependence, including primary codes, documentation requirements, and common coding pitfalls.
Complete code families applicable to Benzodiazepine Dependence
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| F13.20 | Sedative, hypnotic or anxiolytic dependence, uncomplicated | Use when there is documented evidence of benzodiazepine dependence without complications. |
|
| F13.21 | Sedative, hypnotic or anxiolytic dependence, in remission | Use when the provider documents that the dependence is in remission. |
|
| F13.23 | Sedative, hypnotic or anxiolytic withdrawal | Use when withdrawal symptoms are documented. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutBenzodiazepine Dependence
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Benzodiazepine Dependence.
Lack of specific symptom documentation
Impact
Clinical: Inaccurate clinical picture, Regulatory: Potential audit issues, Financial: Incorrect reimbursement
Mitigation
Ensure detailed symptom documentation, Use templates for consistency
Coding both abuse and dependence
Impact
Reimbursement: Incorrect DRG assignment, Compliance: Non-compliance with coding guidelines, Data Quality: Inaccurate clinical data representation
Mitigation
Use only the dependence code when both are documented.
Documentation of dependence criteria
Impact
Failure to document DSM-5 criteria for dependence
Mitigation
Use structured templates to ensure all criteria are documented